This topic contains a solution. Click here to go to the answer

Author Question: When the postsynaptic cell is not depolarized, NMDA receptors a. allow both sodium and calcium to ... (Read 65 times)

WhattoUnderstand

  • Hero Member
  • *****
  • Posts: 517
When the postsynaptic cell is not depolarized, NMDA receptors
 
  a. allow both sodium and calcium to enter the cell.
 b. are blocked by a molecule of calcium.
 c. are blocked by a molecule of magnesium
 d. allow potassium to leave the cell.

Question 2

Long-term potentiation (LTP) in the hippocampus probably involves _________ receptors.
 
  a. GABA
 b. THC
 c. nicotinic acetylcholine
 d. NMDA glutamate



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

TINA

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

c

Answer to Question 2

d




WhattoUnderstand

  • Member
  • Posts: 517
Reply 2 on: Jun 21, 2018
Excellent


strudel15

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library